(Q38124052)

29 August 2017

Osteoporosis in older persons: current pharmacotherapy and future directions (English)

1 reference

29 August 2017

0 references

0 references

Gustavo Duque

1

0 references

language of work or name

English

0 references

publication date

26 July 2013

1 reference

Expert Opinion on Pharmacotherapy

29 August 2017

1 reference

29 August 2017

14

1 reference

29 August 2017

14

1 reference

29 August 2017

1949-1958

1 reference

Second Hip Fracture in Older Men and Women

29 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.822861

Estimation of the prevalence of low bone density in Canadian women and men using a population-specific DXA reference standard: the Canadian Multicentre Osteoporosis Study (CaMos).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.822861

Osteoporotic fractures in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.822861

Bone microarchitecture and strength

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.822861

Construction of the femoral neck during growth determines its strength in old age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.822861

Pathogenesis of osteoporosis: concepts, conflicts, and prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.822861

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.822861

Understanding the mechanisms of senile osteoporosis: new facts for a major geriatric syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.822861

Pathophysiology of osteoporosis: new mechanistic insights

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.822861

Estrogen deficiency and bone loss: an inflammatory tale

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.822861

Osteocyte signaling in bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.822861

Bone and fat connection in aging bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.822861

Cathepsin K: its skeletal actions and role as a therapeutic target in osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.822861

Regulation of osteoclast differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.822861

Role of RANK ligand and denosumab, a targeted RANK ligand inhibitor, in bone health and osteoporosis: a review of preclinical and clinical data

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.822861

Mechanical stimuli and bone health: what is the evidence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.822861

Antiresorptive therapies for osteoporosis: a clinical overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.822861

How strontium ranelate, via opposite effects on bone resorption and formation, prevents osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.822861

Optimal use of vitamin D when treating osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.822861

Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.822861

Update on estrogens and the skeleton

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.822861

The WHI: the effect of hormone replacement therapy on fracture prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.822861

Clinical review. Comparative effectiveness of drug treatments to prevent fragility fractures: a systematic review and network meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.822861

Oral bisphosphonate compliance and persistence: a matter of choice?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.822861

The role of zoledronic acid in the management of osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.822861

Zoledronic acid and clinical fractures and mortality after hip fracture

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.822861

The bisphosphonates: risks and benefits of long term use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.822861

Denosumab, a RANK ligand inhibitor, for postmenopausal women with osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.822861

A review of the efficacy and safety of denosumab in postmenopausal women with osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.822861

Anabolic therapies for osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.822861

Update in new anabolic therapies for osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.822861

The impact of teriparatide adherence and persistence on fracture outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.822861

Efficacy and safety of pharmacological agents in managing osteoporosis in the old old: review of the evidence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.822861

Maintenance of antifracture efficacy over 10 years with strontium ranelate in postmenopausal osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.822861

Adverse drug reactions to osteoporosis treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.822861

Potential new drug targets for osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.822861

Monoclonal antibodies for the treatment of osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.822861

Individualizing osteoporosis therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.822861

Best practices in secondary fracture prevention: fracture liaison services

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.822861

Monitoring osteoporosis treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.822861

Clinical utility of serum bone turnover markers in postmenopausal osteoporosis therapy monitoring: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.822861

Safety and efficacy of risedronate in reducing fracture risk in osteoporotic women aged 80 and older: implications for the use of antiresorptive agents in the old and oldest old.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.822861

Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.822861

Reducing hip fracture risk with risedronate in elderly women with established osteoporosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.822861

Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.822861

Strontium ranelate reduces the risk of vertebral and nonvertebral fractures in women eighty years of age and older

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.822861

Efficacy and safety of a once-yearly intravenous zoledronic acid 5 mg for fracture prevention in elderly postmenopausal women with osteoporosis aged 75 and older

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.822861

Assessment of Fracture Risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.822861

Alendronate Treatment in Women With Normal to Severely Impaired Renal Function: An Analysis of the Fracture Intervention Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.822861

Treatment with Denosumab Reduces the Incidence of New Vertebral and Hip Fractures in Postmenopausal Women at High Risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.822861

10.1517/14656566.2013.822861

21 January 2018

Identifiers

DOI

1 reference

29 August 2017

1 reference

PubMed ID

23885760